Bevacizumab Therapy May Contribute to Irradiation Deferral in Patients With Breast Cancer and With Central Nervous System Metastases: Findings of a Case Series-Reference-Cited by-同舟云学术

Bevacizumab Therapy May Contribute to Irradiation Deferral in Patients With Breast Cancer and With Central Nervous System Metastases: Findings of a Case Series

Published:2012-08 Issue:4 Volume:12 Page:282-286
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Kountourakis Panteleimon,Dokou Anna,Kardara Eugenia,Kaltsas Serafeim,Doufexis Demetrios,Tzovaras Alexandros,Mourgela Sofia,Ardavanis Alexandros

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha and carbonic anhydrase IX in human tumours;Jubb;J Clin Pathol,2004

2. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer;Toi;Clin Cancer Res,1995

3. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma;Gasparini;J Natl Cancer Inst,1997

4. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer;Miller;N Engl J Med,2007

5. Bevacizumab combined with two-weekly paclitaxel as first-line therapy for metastatic breast cancer;Kountourakis;Anticancer Res,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurologic and Medical Management of Brain Tumors;Neurologic Clinics;2018-08

2. Medical management of brain tumors and the sequelae of treatment;Neuro-Oncology;2014-10-30

3. Antiangiogenic Therapy in Patients With HER2-Positive Metastatic Breast Cancer: A Case Series;Clinical Breast Cancer;2014-06

4. Update on bevacizumab and other angiogenesis inhibitors for brain cancer;Expert Opinion on Emerging Drugs;2013-05-14